Global Stem Cell Banking Market Surpasses USD 15 Bn by 2027: A Result of Flexible Guidelines and Increasing R&D and Investments. What Awaits the Future of Stem Cell Banking? : Ken Research

 Buy Now

1. Enhancing Global Stem Cell Market: The International Society for Stem Cell Research Proposes Standards for Research Reproducibility Across Laboratories and Cell Lines.

Click to Read Full Article: Global Stem Cell Banking Market

The ISSCR Guidelines address the international diversity of cultural, political, legal, and ethical issues associated with stem cell research and its translation to medicine. The guidelines were updated in 2021 which include new recommendations to address the recent scientific advances involving embryos, stem cell-based embryo models, chimeras, organoids, and genome editing.

National and international repositories should accept deposits of newly derived stem cell lines to preserve them, maintain them to a high standard, and ensure their authenticity. Repositories are encouraged to distribute them internationally to enable their dissemination. Researchers are encouraged to deposit data on stem cell lines into registries.  

2. Driving Forces Behind the Global Stem Cell Banking Market: Research & Development, Regenerative Medicine Advancements, and Increased Investments.

To learn more about this report Download a Free Sample Report

• Global share of deaths due to NCDs are increasing every year. For instance, in 2022 total number of deaths due to NCDs reached ~41 Mn, equivalent to 74% of all deaths globally. Stem cells can be cultured and developed into new tissue that can be used in regenerative medicine and transplantation.
• Certain types of stem cells can be utilized by researchers to test the safety and quality of investigational drugs prior to their use in human trials.
• CIRM is the leading financial supporter of stem cell research apart from the NIH. It offers funding for research, development, translational and clinical trials.
• There is a continuous increase in R&D and clinical trials for stem cells and gene therapy.

3. The Impact of COVID-19 on the Global Stem Cell Banking Market: Worldwide Lockdown and Logistics Restrictions Hamper Growth.

Visit this Link: – Request for custom report

• The French Cord Blood Bank (CBB) Network collected 4,392 umbilical cord blood (UCB) units in 2020, a decrease from 7,989 units collected in 2019.
• The global healthcare services have been significantly impacted by COVID-19 pandemic. Stem cell transplantation, a preferred treatment for various diseases, requires continuous operation of stem cell collection facilities while implementing safety protocols.
• However, the implementation of COVID-19 restrictions and adherence to national and international guidelines necessitated additional measures to ensure the secure collection of stem cells from both patients and donors. Consequently, the overall stem cell banking market experienced a decline.

Europe and LAMEA Stem Cell Banking Market Surpasses USD 2 Bn in 2022: Revolutionizing Healthcare through Stem Cell Banks and AI Applications and What’s more? Ken Research

 Buy Now

1. Cooperation Fuels Growth in Europe's Stem Cell Banking Market: Collaborative Efforts between Stem Cell Banks and Maternity Clinics for Vital Stem Cell Acquisition.

The European stem cell banks are broadening their service offerings through a merger, which now involves producing advanced therapy medicinal products using mesenchymal stem cells. These products \are utilized for experimental treatment in specialized medical institutions and for developing their own Cell & Gene Therapies.

The utilization of private storage has undergone a notable shift, moving away from treating diseases related to the blood and immune system and toward the realm of regenerative medicine.

The demand for stem cell banking is increasing because of the strong collaboration between maternity clinics and gynecologists, allowing for the collection of the freshest and most crucial stem cells right after childbirth.

Numerous companies in the area are actively working to stimulate the growth of the market. One example is Vita34, which partners with multiple maternity facilities in Europe. They consistently train their clinic staff to professionally collect umbilical cord blood and tissue, along with other relevant responsibilities, following the relevant national regulations.

Also, Check Market Sizing of Global Stem Cell Banking Market

2. UAE Government Eases Regulations to Attract Foreign Investment and Enhance Healthcare Standards in LAMEA Stem Cell Banking Market.

The UAE is actively working towards establishing the first Stem Cells Bank in the MENA region, positioning the country as a hub for stem cell tourism.

In the region, several hospital construction projects are underway, with the Dubai Health Authority leading efforts to integrate medical technology into the development of smart cities.

To attract foreign investment and improve healthcare standards, the UAE government is implementing regulatory relaxations. Notably, the government has allocated a significant portion, 8.4% of its total budget, to healthcare for the period of 2022-2028.

3. Emerging Trends in the Global Stem Cell Banking Market: AI Applications, Modernization of Storage, Growing Approvals, and Start-up Surge.

Download a Free Sample Report

AI plays a crucial role in various aspects of stem cell research, including understanding cell behavior, identifying cell types, characterizing cells through mathematical models, and predicting transplantation risks.

Advancements in storage technology, such as the transition to multi-compartment storage bags, enhance flexibility and viability. The BioArchive® System, a fully automated storage and retrieval system, revolutionizes cryopreservation of valuable cell samples.

The FDA continues to expand its list of approved stem cell therapies and associated diseases based on positive clinical trial outcomes. Currently, FDA-approved stem cell products primarily target blood-related disorders.

Notable startups in the market, like Mogrify, Aspen Neuroscience, and Cellino Bio, have secured substantial funding for their promising ventures.

Major Players Mentioned in the Report:

• CBR Systems
• CryoCell
• ViaCord
• Stemcyte Inc,
• Sartorius
• Smart Cells International Ltd.
• VITA 34
• Global Cord Blood Corporation
• Life Cell
• Cord Life

Key Target Audience – Organizations and Entities Who Can Benefit by Subscribing This Report:

• Stem Cell Banking Companies
• Biopharmaceuticals Companies
• Cord Blood Banks
• Machinery and Equipment Suppliers for Stem Cell Banking
• Cryogenic Healthcare Equipment Manufacturers
• Biotechnology - Therapeutics and Diagnostics Companies
• Pharmaceutical Companies
• World Marrow Donor Association
• Cord Blood Association
• The International Stem Cell Banking Initiative (ISCBI) – PubMed
• Healthcare Research Institutes
• Healthcare Technology Research Institutes
• Healthcare Technology Regulatory Authorities
• Government Ministries and Departments of Healthcare

Time Period Captured in the Report:

• Historical Period: 2017-2022
• Base Year: 2022
• Forecast Period: 2022-2028

For more insights on market intelligence, refer to the link below: –

Global Stem Cell Banking Industry

Related Reports by Ken Research: –

Global Stem Cell Banking Market

UAE Health Tech Market Outlook to 2026

Global Stem Cell Banking Market is expected to reach a market size of ~US$ 15 billion by 2028: Ken Research

 Buy Now

What Is the Size of Global Stem Cell Banking Industry?

Global Stem Cell Banking market is growing at a CAGR of ~% in 2017-2022 and is expected to reach ~USD 15 Bn by 2028. The Stem Cell Banking Market is largely driven by rising prevalence of fatal chronic diseases such as cancer, cardiovascular disease, neurological disorders, immunological disorders, and other rare metabolic diseases.

High operational costs associated with stem cell banking, along with stringent regulatory frameworks, are impeding the growth of the stem cell banking market. The growing newborn population worldwide is another driving factor of the stem cell banking market.

The ongoing COVID-19 pandemic increases the morbidity of cord blood transplantation (CBT) recipients globally, but stem cell procedures were slowed in 2020 due to the lockdown imposed by several governments across countries to prevent the virus's spread, resulting in a decline in stem cell banking growth.

Global Stem Cell Banking Market By Source

The Global Stem Cell Banking market is segmented by Source into Placental Stem Cells (PSCS), Adipose Tissue-Derived Stem Cells (ADSCS), Bone Marrow-Derived Stem Cells (BMSCS), Human Embryo-Derived Stem Cells (HESCS), Dental Pulp-Derived Stem Cells (DPSCS) and Others. The Placental Stem Cells (PSCS) segment held the largest market share of the global stem cell banking market in 2022.

The growth is mainly attributed to the significant rise in the number of placental and cord banks, notably in the USA and Europe. According to the World Marrow Donor Association (WMDA), a Netherlands-based organization that promotes multilateral cooperation and best practices for the benefit of blood stem cell donors and transplant patients, nearly 8,04,193 cord blood units are currently available worldwide.

Global Stem Cell Banking Market By Service Type

The Global Stem Cell Banking market is segmented by Service type into Sample Collection and Transportation, Sample Preservation and Storage, Sample Analysis and Sample Processing. The Sample Preservation and Storage segment held the largest market share of the Global Stem Cell Banking Market in 2022.

Stem cell banks primarily store samples of human stem cells for potential future use in stem cell treatments, such as bone marrow transplantation (BMT), Peripheral blood stem cell transplant, and Cord blood transplant. The emergence of a growing number of stem cell banks across countries resulted in more stored stem cell samples, which are used in therapies and regenerative medicine in the long term.

Global Stem Cell Banking Market By Application

The Global Stem Cell Banking market is segmented by Application into Personalized Banking Application, Research Applications (Disease Treatment Studies, Life Science Research, Drug Discovery) and Clinical Application (Hematopoietic Disorders, Autoimmune Disorders, Others). The Personalized Banking Applications segment held the largest market share of the Global Stem Cell Banking Market in 2022.

The growth is primarily attributed to service providers' premium pricing of service plans and the benefits offered by personalized banking. The Research Application segment is expected to grow at the fastest CAGR during the forecasted period 2022-2028, owing to rising R&D expenditure in the biopharmaceutical industry and rising government initiatives on drug discovery.

Request For Free Sample Report @ https://www.kenresearch.com/sample-report.php?Frmdetails=NTk2MTMz

Global Stem Cell Banking Market By Cell Type

The Global Stem Cell Banking market is segmented by Cell type into Umbilical Cord Stem Cell, Adult Stem Cell and Embryonic Stem Cell. The Adult Stem Cells segment held the largest market share of the Global Stem Cell Banking Market in 2022, owing to their commonality of origin in the human body (bone marrow, and fat), where they mostly reside.

The growing global prevalence of cancer and blood-related diseases, such as leukemia, lymphoma, neuroblastoma, and multiple myeloma is driving demand for adult stem cells, which replace damaged cells caused by such diseases to decrease inflammation and fight infection. According to the American Cancer Society, a worldwide voluntary health organization dedicated to cancer eradication, nearly 60,650 new cases of leukemia is being discovered in the United States in 2022, with 24,000 deaths from the disease.

Global Stem Cell Banking Market By Geography

The Global Stem Cell Banking market is segmented by geography into North America, Europe, Asia- pacific and LAMEA. North America accounted for the largest share of the Global Stem Cell Banking Market in 2022 and will remain dominant during the forecast period (2022-2028), owing to the increasing incidence rates of diseases, such as cancer, neurological disorders, and diabetes.

For instance, according to the American Cancer Society, cancer continues to be the second leading cause of death in the USA, after cardiovascular disease. In 2022, USA is expected to see 1.9 million new cancer cases and 609,360 cancer deaths, for a total of 1,670 deaths per day. The growing government initiatives and investments in stem cell therapies are contributing to the region's growth in stem cell banking. For instance, in March 2020, according to CTV News, a Canadian news platform, the Canadian government invested almost US$ 7 million in the Stem Cell Network's competitive research funding program.

Request for Custom Report @ https://www.kenresearch.com/ask-customization.php?Frmdetails=NTk2MTMz

Competition Scenario In Global Stem Cell Banking Market

The Global Stem Cell Banking Market is highly competitive with ~100 players which include globally diversified players, several regional players as well as a significant number of country-niche players with their niche in pharma and diagnostics solutions, and technologies, such as molecular imaging technologies (optical molecular imaging, positron emission tomography, single-photon emission computed tomography, and computed tomography) to research disease mechanisms and evaluation of therapeutic interventions. Country-Niche players comprise about ~45% of the total competitors, while regional players represent a share of ~35%. Some of the major players in the market include CBR.

What is the Expected Future Outlook for the Overall Global Stem Cell Banking Market Across the globe?

The Global Stem Cell Banking market was valued at USD ~billion in 2022 and is anticipated to reach USD ~15 billion by the end of 2028, witnessing a CAGR of ~% during the forecast period 2022-2028. The realistic growth scenario represents the most likely scenario as per current market conditions. This scenario assumes that there will be no overall impact on the market due to any potential COVID-19 waves in the future.

The Global Stem Cell Banking market is driven by rising prevalence of fatal chronic diseases such as cancer, cardiovascular disease, neurological disorders, immunological disorders, and other rare metabolic diseases. However, the market is also constantly being influenced by rapid development in technology, product innovation, and diversification in some countries.

With the increasing collaboration and emergence of new products, the Global Stem Cell Banking market is changing rapidly. For instance, In September 2021, Generate Life Sciences, a USA based biotechnology company, announced that over 10,000 families had enrolled in the Newborn Possibilities Program (NPP) provided by the company's newborn stem cell preservation bank, Cord Blood Registry (CBR).

In July 2021, ViaCord launched newborn digestive health screen tests for genetic markers of Celiac disease and primary lactose intolerance. The screen is to be performed with a small amount of the collected cord blood. The global stem cell banking market is forecasted to continue the exponential growth at ~12% during the forecast period. The major driving factor contributing to the rising prevalence of fatal chronic diseases, and the growing newborn population worldwide. Though the market is highly competitive with around ~100 participants, few country-niche players control the dominant share and regional players also hold a significant share.

For more insights on the market intelligence, refer to below link:-

Global Stem Cell Banking Market